Noema Pharma raised CHF 103 million in Series B funding led by Forbion and joined by Jeito Capital, UPMC, Sofinnova Partners, Gilde Healthcare and Invus

Biotech Health services

Investments

03 March 2023

Noema Pharma (company)

Biotech Health services

Total investments received (USD): 206.76m

Round value (USD): 109.46m

Round investors: Forbion Capital Partners Gilde Healthcare Invus Jeito Capital Polaris Partners Sofinnova Partners UPMC Enterprises

Industry: Biotech Health services

Biotech Health services Manufacturing

Investments 09 April 2023